ABSCI CORP (ABSI:NASDAQ)
$7.78 0.14 (1.8325%)
Analysed ABSCI CORP (ABSI:NASDAQ) News Sources
Absci (ABSI) Is Up 37.8% After ABS-201 Data And Equity Raise - Has The Bull Case Changed?
26-06-2026
yahoo.com
Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy
26-06-2026
pharmaceutical-technology.com
Absci Raises $100 Million In Equity To Fund AI-Designed Hair Loss And Endometriosis Program
27-06-2026
yahoo.com
Here's Why Absci Corporation (ABSI) is a Great Momentum Stock to Buy
02-07-2026
yahoo.com
Wall Street Analysts Predict a 28.3% Upside in ABSCI CORP (ABSI): Here's What You Should Know
13-07-2026
yahoo.com
Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026
14-07-2026
yahoo.com
As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22
15-07-2026
yahoo.com
Viking Therapeutics to Report Q2 Earnings: What's in Store for the Stock?
17-07-2026
yahoo.com
A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed
24-07-2026
yahoo.com
Are Medical Stocks Lagging ABSCI CORP (ABSI) This Year?
30-07-2026
yahoo.com
What is the current price of ABSCI CORP (ABSI:NASDAQ)?
The current price of ABSCI CORP (ABSI:NASDAQ) is $7.78.
ABSCI CORP (ABSI:NASDAQ) absolute price change since previous trading day?
The absolute price change of ABSCI CORP (ABSI:NASDAQ) since the previous trading day is $0.14.
ABSCI CORP (ABSI:NASDAQ) percentage price change since previous trading day?
The percentage price change of ABSCI CORP (ABSI:NASDAQ) since the previous trading day is 1.8325%.
What is the most recent average sentiment score for ABSCI CORP (ABSI:NASDAQ)?
The most recent average sentiment score for ABSCI CORP (ABSI:NASDAQ) is 62 out of 100.
What is the most recent average sentiment for ABSCI CORP (ABSI:NASDAQ)?
The most recent sentiment for ABSCI CORP (ABSI:NASDAQ) is .
SEC-8K** Filing Available For ABSCI CORP (ABSI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.